- Home
- ICAD vs BRNS Comparison
ICAD vs BRNS Comparison
Compare ICAD & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICAD
- BRNS
- Stock Information
- Founded
- ICAD 1984
- BRNS 2016
- Country
- ICAD United States
- BRNS United Kingdom
- Employees
- ICAD N/A
- BRNS N/A
- Industry
- ICAD Medical/Dental Instruments
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- ICAD Health Care
- BRNS Health Care
- Exchange
- ICAD Nasdaq
- BRNS Nasdaq
- Market Cap
- ICAD 103.3M
- BRNS 40.0M
- IPO Year
- ICAD 1986
- BRNS 2021
- Fundamental
- Price
- ICAD $3.72
- BRNS $0.90
- Analyst Decision
- ICAD Hold
- BRNS Strong Buy
- Analyst Count
- ICAD 1
- BRNS 1
- Target Price
- ICAD N/A
- BRNS $3.00
- AVG Volume (30 Days)
- ICAD 249.6K
- BRNS 10.9K
- Earning Date
- ICAD 08-12-2025
- BRNS 08-07-2025
- Dividend Yield
- ICAD N/A
- BRNS N/A
- EPS Growth
- ICAD N/A
- BRNS N/A
- EPS
- ICAD N/A
- BRNS N/A
- Revenue
- ICAD $19,528,000.00
- BRNS $14,969,000.00
- Revenue This Year
- ICAD $3.60
- BRNS N/A
- Revenue Next Year
- ICAD N/A
- BRNS N/A
- P/E Ratio
- ICAD N/A
- BRNS N/A
- Revenue Growth
- ICAD 8.86
- BRNS 4381.74
- 52 Week Low
- ICAD $1.18
- BRNS $0.64
- 52 Week High
- ICAD $4.02
- BRNS $1.58
- Technical
- Relative Strength Index (RSI)
- ICAD 49.12
- BRNS 48.03
- Support Level
- ICAD $3.58
- BRNS $0.83
- Resistance Level
- ICAD $3.92
- BRNS $0.94
- Average True Range (ATR)
- ICAD 0.14
- BRNS 0.05
- MACD
- ICAD -0.02
- BRNS -0.00
- Stochastic Oscillator
- ICAD 33.33
- BRNS 34.88
About ICAD iCAD Inc.
icad Inc is a medical technology company providing cancer detection and therapy solutions. The Company operates in one segment: Detection. The Detection segment includes image analysis and workflow solutions that enable healthcare professionals to serve patients by identifying pathologies, comprehensive range of high-performance, Artificial Intelligence and Computer-Aided Detection (CAD) systems and workflow solutions for 2D and 3D mammography, Magnetic Resonance Imaging and Computed Tomography. The company geographically operates in France, Belgium, Italy, Germany, Switzerland and All other.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.